BRAF and non-small cell lung carcinoma: From 1 January 2016 to 28 February 2020, an overall number of 2342 patients with advanced NSCLC were tested for BRAF mutation, as per clinical practice, by the five Pathology Units involved in the DETECTION_KB study.